ARTBIO
PrivateLast Round
Series B
Jul 29, 2025
Total Funding Raised
$245M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ARTBIO is a biotechnology company that develops targeted alpha radioligand therapies for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTBIO Comparables
Compare ARTBIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aktis Oncology | 88% | |
| Ratio Therapeutics Inc. | 88% | |
| Eli Lilly and Company | 81% |
ARTBIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2025 | ||||
| Series A | Dec 7, 2023 | ||||
| Seed | Jun 21, 2023 |
Key People
Founding team and executive leadership
ARTBIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series B, Series A, Seed |
| B Capital Group | Series B |
| F-Prime Capital | Series A, Seed |
| Alexandria Venture Investments | Series B |
| F-Prime Capital | Series B, Series A, Seed |
| Radforsk | Seed |
| Sofinnova Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 110% MoM.
- Jan 1, 2026
Lead program AB001 is in first-in-human trials.
ARTBIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ARTBIO's valuation, stock price, and market status.
Is ARTBIO a public or private company?
ARTBIO is a private company.
What is the current stock price of ARTBIO?
ARTBIO is a private company with no public stock price. No recent secondary market data is available.
How much is ARTBIO worth (valuation)?
Valuation information for ARTBIO is not publicly available.
Can I buy ARTBIO stock?
ARTBIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ARTBIO's last funding round?
ARTBIO's most recent funding round was Series B on July 29, 2025.
Who are the main investors in ARTBIO?
Key investors in ARTBIO include Omega Funds, B Capital Group, F-Prime Capital, Sofinnova Investments, Third Rock Ventures.
Will ARTBIO IPO soon?
No public IPO plans have been announced for ARTBIO.
How can I track ARTBIO secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ARTBIO's secondary market activity and sign up for updates.